rosiglitazone has been researched along with Adenocarcinoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fröhlich, E; Wahl, R | 1 |
| Herrigel, DJ; Moss, RA | 1 |
| Chen, J; Chen, W; Cheng, Q; Jiang, H; Miao, C; Ren, Y; Sun, Z; Wang, H; Weng, M; Wu, Q; Xu, P; Xu, Y; Zhong, J; Zhu, M | 1 |
| Bonnans, C; Chanez, P; Godard, P; Gras, D; Urbach, V; Vachier, I | 1 |
| Asp, ML; Belury, MA; Tian, M; Wendel, AA | 1 |
| Choudhary, R; Li, H; Nemenoff, RA; Sorenson, AL; Weiser-Evans, MC; Winn, RA | 1 |
| Amin, J; Crossno, JT; Joyal, T; Li, H; Nemenoff, RA; Poczobutt, J; Sorenson, AL; Sullivan, T; Weiser-Evans, MC | 1 |
| Iyengar, S; Peehl, DM; Roberts, RL; Shappell, SB; Xu, Y | 1 |
| Burgermeister, E; Liscovitch, M; Tencer, L | 1 |
| Casini, A; Ceni, E; Crabb, DW; Galli, A; Grappone, C; Mello, T; Milani, S; Salzano, R; Surrenti, C; Surrenti, E | 1 |
| Feng, Y; Hörling, J; Hu, X; Leng, Y; Liu, X; Sydow-Bäckman, M; Yang, YS; Yu, JH; Zhao, XF; Zierath, JR | 1 |
| Auwerx, J; Briggs, M; Chen, I; Desreumaux, P; Fruchart, JC; Geboes, K; Heyman, R; Lefebvre, AM; Najib, J | 1 |
| Baek, SJ; Eling, TE; Hsi, LC; Ikawa, H; Kameda, H; Kamitani, H; Nixon, JB | 1 |
| Ghosh, B; Goel, A; Parmar, VS; Prasad, AK; Saini, N | 1 |
| Ahmad, S; Chhabra, R; Ghosh, B; Goel, A; Parmar, VS; Prasad, AK; Saini, N | 1 |
2 review(s) available for rosiglitazone and Adenocarcinoma
| Article | Year |
|---|---|
The current role of targeted therapies to induce radioiodine uptake in thyroid cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Chromans; Female; Forecasting; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Iodine Radioisotopes; Male; Molecular Targeted Therapy; Pyrazoles; Pyrimidines; Risk Assessment; Rosiglitazone; Thiazolidinediones; Thyroid Neoplasms; Treatment Outcome; Troglitazone | 2014 |
Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Diabetes Complications; Humans; Hypoglycemic Agents; Insulin; Liver Neoplasms; Metformin; Non-alcoholic Fatty Liver Disease; Pancreatic Neoplasms; Pioglitazone; Precancerous Conditions; Receptors, Somatomedin; Risk Factors; Rosiglitazone; Thiazolidinediones | 2014 |
13 other study(ies) available for rosiglitazone and Adenocarcinoma
| Article | Year |
|---|---|
MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
Topics: Adenocarcinoma; Animals; Cell Communication; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Progression; DNA-Binding Proteins; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Staging; Oncogene Proteins; Phenotype; PPAR gamma; RAW 264.7 Cells; Receptors, Cell Surface; RNA Interference; Rosiglitazone; Signal Transduction; STAT6 Transcription Factor; Thiazolidinediones; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment | 2016 |
Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
Topics: Adenocarcinoma; Anilides; Bronchi; Calcium Signaling; Cell Division; Cell Line, Transformed; Cell Line, Tumor; Chromans; Humans; Hypoglycemic Agents; Lung Neoplasms; PPAR gamma; Receptors, G-Protein-Coupled; Respiratory Mucosa; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Troglitazone | 2009 |
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Topics: Adenocarcinoma; Adiponectin; Animals; Autophagy; Blood Glucose; Cachexia; Colonic Neoplasms; Crosses, Genetic; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Neoplasm Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Random Allocation; Rosiglitazone; Thiazolidinediones; Weight Loss | 2010 |
Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
Topics: Adenocarcinoma; Blotting, Western; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Lung Neoplasms; Matrix Metalloproteinases; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Snail Family Transcription Factors; Thiazolidinediones; Transcription Factors | 2010 |
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis.
Topics: Adenocarcinoma; Animals; Bone Marrow; Coculture Techniques; Disease Progression; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Hypoglycemic Agents; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myeloid Cells; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Topics: Adenocarcinoma; Cell Division; Gene Expression Regulation, Neoplastic; Humans; Male; Phenotype; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tumor Cells, Cultured | 2003 |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Breast Neoplasms; Caveolin 1; Caveolin 2; Caveolins; Cell Differentiation; Cell Line; Chromans; Colonic Neoplasms; Dimerization; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; Kidney; Ligands; Macromolecular Substances; Membrane Microdomains; Neoplasm Proteins; Phenotype; Phenylacetates; Prostaglandin D2; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured | 2003 |
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Male; Matrix Metalloproteinases; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Pioglitazone; Plasminogen Activators; PPAR gamma; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2004 |
Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Biological Transport; Cell Line, Tumor; Colonic Neoplasms; Coumarins; Genes, Reporter; Glucose; Humans; Mice; Muscle, Skeletal; Oxazoles; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2007 |
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
Topics: Adenocarcinoma; Animals; beta Catenin; Chromans; Colorectal Neoplasms; Cyclooxygenase 2; Cytoskeletal Proteins; HT29 Cells; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Troglitazone | 1998 |
Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Colorectal Neoplasms; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Isoenzymes; Ligands; Membrane Proteins; Models, Biological; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Receptor Cross-Talk; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway.
Topics: Adenocarcinoma; Apoptosis; Caspases; Cell Proliferation; Coumarins; Cytochromes c; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mitochondria; Mitogen-Activated Protein Kinases; NF-kappa B; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured | 2009 |
DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: an integrated proteomics and transcriptomics approach.
Topics: Actins; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Cell Movement; Coumarins; Cytoskeleton; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Oncogene Proteins; Protein Deglycase DJ-1; Proteomics; rho GTP-Binding Proteins; rho Guanine Nucleotide Dissociation Inhibitor alpha; Signal Transduction; Transcriptome | 2012 |